Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
66.61
-1.97 (-2.87%)
At close: May 22, 2026, 4:00 PM EDT
67.69
+1.08 (1.62%)
After-hours: May 22, 2026, 7:16 PM EDT
Nektar Therapeutics Stock Forecast
Stock Price Forecast
The 10 analysts that cover Nektar Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $153.25, which forecasts a 130.07% increase in the stock price over the next year. The lowest target is $80 and the highest is $192.
Price Target: $153.25 (+130.07%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Nektar Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 6 | 6 | 6 |
| Buy | 1 | 1 | 1 | 0 | 0 | 1 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 7 | 7 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Hold Maintains $95 → $80 | Hold | Maintains | $95 → $80 | +20.10% | May 11, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $105 → $192 | Buy | Maintains | $105 → $192 | +188.25% | May 8, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $123 → $151 | Strong Buy | Maintains | $123 → $151 | +126.69% | Apr 21, 2026 |
| Wedbush | Wedbush | Hold Maintains $70 → $95 | Hold | Maintains | $70 → $95 | +42.62% | Apr 21, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $165 → $185 | Strong Buy | Maintains | $165 → $185 | +177.74% | Apr 20, 2026 |
Financial Forecast
Revenue This Year
41.85M
from 55.23M
Decreased by -24.22%
Revenue Next Year
37.65M
from 41.85M
Decreased by -10.05%
EPS This Year
-9.24
from -9.73
EPS Next Year
-11.30
from -9.24
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 47.0M | 47.9M | ||||||
| Avg | 41.9M | 37.6M | ||||||
| Low | 23.5M | 7.9M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -14.9% | 14.5% | ||||||
| Avg | -24.2% | -10.0% | ||||||
| Low | -57.4% | -81.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | -8.00 | -7.23 | |||||
| Avg | -9.24 | -11.30 | |||||
| Low | -10.80 | -13.76 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | - | - | |||||
| Avg | - | - | |||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.